Idea principal
Among 6893 Chinese adults aged 60 and over, 37.2% had sarcopenia, and over 3 years sarcopenia was associated with higher odds of new daily-living disability (ADLs OR 1.58; IADLs OR 1.87). Even possible sarcopenia carried raised odds, but the numbers come from a single national survey and remain associations.
Study design
Estudio de cohorte
Reading basis
Published abstract
Reading focus
Association & confounding
Esta explicación editorial está disponible en inglés, chino simplificado y chino tradicional. Esta interfaz muestra la lectura en inglés.
Pregunta de investigación
Sarcopenia, loss of muscle mass and function, is tied to disability in older age, yet studies disagree because they define it differently. The authors tested the link using one standard algorithm in a national sample.
Población y método
Nationally representative longitudinal study using China Health and Retirement Longitudinal Study (CHARLS) 2015 data on participants aged at least 60 years. Sarcopenia was classified with the Asian Working Group for Sarcopenia 2019 algorithm. Outcomes were disability in basic activities of daily living (ADLs) and instrumental activities of daily living (IADLs). Logistic regression assessed cross-sectional associations and associations with new-onset disability over 3 years of follow-up.
Resultados
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1Cross-sectionally, 37.2% of 6893 participants had sarcopenia, and any form was associated with ADLs and IADLs disability.
- 2Over 3 years, 786 people (16.5%) developed new ADLs disability and 980 (22.5%) developed new IADLs disability.
- 3For ADLs disability, odds were higher with possible sarcopenia (OR 1.62, 95% CI 1.34-1.95), sarcopenia (OR 1.58, 95% CI 1.18-2.11) and total sarcopenia (OR 1.58, 95% CI 1.34-1.88) versus none.
- 4For IADLs disability, ORs were 1.68 (95% CI 1.41-2.00) for possible sarcopenia, 1.87 (1.40-2.51) for sarcopenia and 1.71 (1.45-2.00) for total sarcopenia. Urban residents had higher risk (ORs 2.14 to 2.44), and possible sarcopenia was linked to ADLs disability in men (OR 1.68, 95% CI 1.26-2.25) and IADLs disability in women (OR 1.98, 95% CI 1.56-2.52).
Límites e incertidumbre
- 1Odds ratios from logistic regression overstate relative risk when outcomes are common, as 16.5% and 22.5% are.
- 2The abstract does not list which variables were adjusted for, so confounding by chronic disease cannot be assessed.
- 3Sarcopenia was measured once at baseline and the follow-up was only 3 years; people lost to follow-up may differ.
- 4Urban, rural and sex differences come from interaction tests in subgroups and need confirmation. This reading rests on the abstract only.
Relevancia práctica
Weak grip strength, slow walking or low muscle mass in later life are markers worth taking seriously, even before full sarcopenia criteria are met. The study cannot say that building muscle will prevent disability. A clinician can assess strength and function and advise on resistance training and nutrition.
Tus datos
Sarcopenia is diagnosed with grip strength, walking speed and body composition tests, which a wearable does not do. Smart scales estimate muscle mass roughly, and step counts or walking pace from a watch can give a rough trend. Compare these on the same device over months and share concerns with a clinician.
Cómo interpretar la evidencia
Exposure precedes follow-up outcomes, but confounding and reverse causation can remain. A hazard ratio is not an individual absolute risk or a demonstrated intervention effect.
Resumen estructurado de los autores English
El resumen original en inglés se reproduce con atribución bajo la licencia indicada. Es una fuente, no una interpretación de MoveVitals. El análisis preparado figura arriba; verifica los resultados importantes en la fuente.
Objectives
Sarcopenia is associated with functional disability in older adults. However, no consistent conclusions have been reached considering the differences in the measurement and criteria of sarcopenia. We aimed to examine the association between sarcopenia status and functional disability based on China Health and Retirement Longitudinal Study (CHARLS).
Design
A nationally representative longitudinal study.
Setting and participants
Participants aged at least 60 years old from the CHARLS 2015y were included.
Measurements
Sarcopenia was assessed according to the Asian Working Group for Sarcopenia 2019 algorithm. The outcomes of this study were basic activities of daily living (ADLs) and instrumental activities of daily living (IADLs). The logistic regression model was conducted to analyze the cross-sectional and longitudinal associations between sarcopenia status and ADLs and IADLs disability.
Results
In the cross-sectional study, 37.2% of the 6893 participants were defined as having sarcopenia. Any form of sarcopenia was associated with ADLs and IADLs disability. During three years of follow-up, 786 (16.5%) participants developed new-onset ADLs disability, and 980 (22.5%) participants developed new-onset IADLs disability. Compared with the no-sarcopenia, participants with possible sarcopenia (OR: 1.62, 95%CI: 1.34-1.95), sarcopenia (OR: 1.58, 95%CI: 1.18-2.11), or total sarcopenia (OR: 1.58, 95%CI: 1.34-1.88) had a higher risk of ADLs disability. While, the risk of IADLs disability for participants with possible sarcopenia (OR: 1.68, 95%CI: 1.41-2.00), sarcopenia (OR: 1.87, 95%CI: 1.40-2.51), or total sarcopenia (OR: 1.71, 95%CI: 1.45-2.00) was still significantly increased. With statistical interaction between sarcopenia status and residence or sex in ADLs and IADLs disability, older adults in urban, with ORs ranging from 2.14 to 2.44, were at a higher risk of functional disability than those in rural. Possible sarcopenia was associated with a much higher risk of ADLs disability (OR: 1.68, 95%CI: 1.26-2.25) in males and a higher risk of IADLs disability (OR: 1.98, 95%CI: 1.56-2.52) in females.
Conclusions
Sarcopenia was associated with an increased risk of ADLs and IADLs disability among older Chinese adults. Even possible sarcopenia still significantly impacted ADLs and IADLs disability, and this association varied by sex and residence.
Fuentes y atribución
The association between sarcopenia and functional disability in older adults.
Zhou H, Ding X, Luo M.
The journal of nutrition, health & aging · 2024-01-01
DOI: 10.1016/j.jnha.2023.100016 ↗PubMed · 38267154 ↗Europe PMC · Licencia registrada: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interpretación editorial de MoveVitals · contenido educativo · sin revisión clínica individual registrada
Fuentes verificadas 2026-11-01
Guías prácticas
Leer en contexto
ACSM review of 137 reviews: resistance training works, and few programme details matter
The American College of Sports Medicine pooled 137 systematic reviews (over 30,000 healthy adults) and concluded that resistance training beats no exercise for strength, muscle size, power, endurance and several function tests. Few programme details changed results consistently: heavier loads (80% or more of one-repetition maximum) and 2 to 3 sets favoured strength, and at least 10 sets a week favoured muscle size, while training to failure, exercise type and periodization did not. It summarises reviews rather than new trials, gives no pooled effect sizes, and drew mostly on untrained adults and overlapping source trials.
Medicine & Science in Sports & Exercise
Nearly every resistance training plan beat no exercise; heavy loads led for strength
In a network meta-analysis of randomised trials in healthy adults (178 studies and 5097 people for strength, 119 studies and 3364 people for muscle size), nearly all resistance training prescriptions beat no exercise. Higher-load, multiset, thrice-weekly training ranked best for strength (standardised mean difference 1.60, 95% credible interval 1.38 to 1.82) and higher-load, multiset, twice-weekly training for muscle size (0.66, 0.47 to 0.85). Most prescriptions could not be statistically separated from each other (the 95% interval contained zero in 91% of the comparisons between them) and risk of bias was moderate to high, so the rankings are tentative.
British Journal of Sports Medicine
Muscle-strengthening linked to lower risk of death, heart disease, cancer and diabetes
Pooling 16 prospective cohort studies of adults, people who did muscle-strengthening activity had a 15% lower risk of all-cause mortality (RR 0.85, 95% CI 0.79 to 0.93) and a 17% lower risk of both cardiovascular disease and diabetes (RR 0.83 for each) than people who did none. The pooled mortality curve was lowest at about 40 min/week (RR 0.83), but whether larger amounts help or hurt is unclear. All of this is observational, from mostly US self-reported data, and the authors rated the certainty of evidence as very low for most outcomes.
British Journal of Sports Medicine
Protein supplements and weight training: small extra gains, smaller in older adults
Pooling 49 randomised trials with 1,863 healthy adults who did resistance training for at least 6 weeks, protein supplements added 0.30 kg of fat-free mass (95% CI 0.09 to 0.52) and 2.49 kg of one-repetition-maximum strength (0.64 to 4.33) on top of training alone. These gains were small next to the effect of training itself, were weaker with older age, and the suggested plateau near 1.6 g/kg/day was not statistically significant (p=0.079). One author has received funding from the US National Dairy Council, which supported trials in the analysis.
British Journal of Sports Medicine

